De Miranda BR, Goldman SM, Miller GW, Greenamyre JT, Dorsey ER (2022) Preventing Parkinson’s disease: an environmental agenda. J Parkinsons Dis 12(1):45–68. https://doi.org/10.3233/JPD-212922

Article  PubMed  PubMed Central  Google Scholar 

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https://doi.org/10.1038/nrdp.2017.13

Article  PubMed  Google Scholar 

Chaudhuri KR, Azulay JP, Odin P, Lindvall S, Domingos J, Alobaidi A et al (2024) Economic Burden of Parkinson’s Disease: a multinational, Real-World, cost-of-illness study. Drugs Real World Outcomes. https://doi.org/10.1007/s40801-023-00410-1

Article  PubMed  PubMed Central  Google Scholar 

Albarmawi H, Zhou S, Shulman LM, Gandhi AB, Johnson A, Myers DE et al (2022) The economic burden of Parkinson disease among Medicare beneficiaries. J Manag Care Spec Pharm 28(4):405–414. https://doi.org/10.18553/jmcp.2022.28.4.405

Article  PubMed  Google Scholar 

Zhao N, Yang Y, Zhang L, Zhang Q, Balbuena L, Ungvari GS et al (2021) Quality of life in Parkinson’s disease: a systematic review and meta-analysis of comparative studies. CNS Neurosci Ther 27(3):270–279. https://doi.org/10.1111/cns.13549

Article  PubMed  Google Scholar 

Ye H, Robak LA, Yu M, Cykowski M, Shulman JM (2023) Genetics and Pathogenesis of Parkinson’s syndrome. Annu Rev Pathol 18:95–121. https://doi.org/10.1146/annurev-pathmechdis-031521-034145

Article  PubMed  CAS  Google Scholar 

Krzyzanowski B, Searles Nielsen S, Turner JR, Racette BA (2023) Fine particulate matter and Parkinson Disease Risk among Medicare beneficiaries. Neurology 101(21):e2058–e67. https://doi.org/10.1212/WNL.0000000000207871

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cryan JF, O’Riordan KJ, Sandhu K, Peterson V, Dinan TG (2020) The gut microbiome in neurological disorders. Lancet Neurol 19(2):179–194. https://doi.org/10.1016/S1474-4422(19)30356-4

Article  PubMed  CAS  Google Scholar 

Ascherio A, Schwarzschild MA (2019) Lifestyle and Parkinson’s disease progression. Mov Disord 34(1):7–8. https://doi.org/10.1002/mds.27566

Article  PubMed  Google Scholar 

He Y, Peng K, Li R, Zhang Z, Pan L, Zhang T et al (2022) Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson’s disease. J Neurol 269(10):5368–5381. https://doi.org/10.1007/s00415-022-11190-z

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bartl M, Xylaki M, Bahr M, Weber S, Trenkwalder C, Mollenhauer B (2022) Evidence for immune system alterations in peripheral biological fluids in Parkinson’s disease. Neurobiol Dis 170:105744. https://doi.org/10.1016/j.nbd.2022.105744

Article  PubMed  CAS  Google Scholar 

Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657–673. https://doi.org/10.1038/s41577-022-00684-6

Article  PubMed  PubMed Central  CAS  Google Scholar 

Singh K, Sethi P, Datta S, Chaudhary JS, Kumar S, Jain D et al (2024) Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases. Ageing Res Rev 98:102321. https://doi.org/10.1016/j.arr.2024.102321

Article  PubMed  CAS  Google Scholar 

Solleiro-Villavicencio H, Rivas-Arancibia S (2018) Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4(+)T cells in neurodegenerative diseases. Front Cell Neurosci 12:114. https://doi.org/10.3389/fncel.2018.00114

Article  PubMed  PubMed Central  CAS  Google Scholar 

Giri PM, Banerjee A, Ghosal A, Layek B (2024) Neuroinflammation in neurodegenerative disorders: current knowledge and therapeutic implications. Int J Mol Sci 25(7). https://doi.org/10.3390/ijms25073995

Wang P, Yao L, Luo M, Zhou W, Jin X, Xu Z et al (2021) Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson’s disease. Cell Discov 7(1):52. https://doi.org/10.1038/s41421-021-00280-3

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen X, Feng W, Ou R, Liu J, Yang J, Fu J et al (2021) Evidence for Peripheral Immune activation in Parkinson’s Disease. Front Aging Neurosci 13:617370. https://doi.org/10.3389/fnagi.2021.617370

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V et al (2009) Infiltration of CD4 + lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 119(1):182–192. https://doi.org/10.1172/JCI36470

Article  PubMed  CAS  Google Scholar 

Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS (2021) CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson’s disease. Brain 144(7):2047–2059. https://doi.org/10.1093/brain/awab103

Article  PubMed  PubMed Central  Google Scholar 

Kumar BV, Connors TJ, Farber DL, Human T (2018) Cell Development, localization, and function throughout life. Immunity 48(2):202–213. https://doi.org/10.1016/j.immuni.2018.01.007

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu X, Zhu J (2020) CD4 T Helper Cell subsets and Related Human Immunological disorders. Int J Mol Sci 21(21). https://doi.org/10.3390/ijms21218011

Bhattacharyya T, Karnezis AN, Murphy SP, Hoang T, Freeman BC, Phillips B et al (1995) Cloning and subcellular localization of human mitochondrial hsp70. J Biol Chem 270(4):1705–1710. https://doi.org/10.1074/jbc.270.4.1705

Article  PubMed  CAS  Google Scholar 

Caza T, Landas S (2015) Functional and phenotypic plasticity of CD4(+) T cell subsets. Biomed Res Int 2015:521957doi. https://doi.org/10.1155/2015/521957

Article  CAS  Google Scholar 

Luckheeram RV, Zhou R, Verma AD, Xia B (2012) CD4(+)T cells: differentiation and functions. Clin Dev Immunol 2012:925135. https://doi.org/10.1155/2012/925135

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145–173. https://doi.org/10.1146/annurev.iy.07.040189.001045

Article  PubMed  CAS  Google Scholar 

Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19(5):641–644. https://doi.org/10.1016/s1074-7613(03)00296-6

Article  PubMed  CAS  Google Scholar 

Trinchieri G, Sher A (2007) Cooperation of toll-like receptor signals in innate immune defence. Nat Rev Immunol 7(3):179–190. https://doi.org/10.1038/nri2038

Article  PubMed  CAS  Google Scholar 

Zhu J, Jankovic D, Oler AJ, Wei G, Sharma S, Hu G et al (2012) The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37(4):660–673. https://doi.org/10.1016/j.immuni.2012.09.007

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kanno Y, Vahedi G, Hirahara K, Singleton K, O’Shea JJ (2012) Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu Rev Immunol 30:707–731.